HIV (human immunodeficiency virus) is a virus that attacks the body’s immune system. If HIV is not treated, it can lead to AIDS (acquired immunodeficiency syndrome).
About HIV
Learning the basics about HIV can keep you healthy and prevent HIV transmission.
Source: CDC
From an epidemiological standpoint, there were an estimated 37.7 million [30.2–45.1 million] people living with HIV at the end of 2020, over two thirds of whom (25.4 million) are in the WHO African Region. In 2020, 680 000 [480 000–1.0 million] people died from HIV-related causes and 1.5 million [1.0–2.0 million] people acquired HIV.
Source: WHO
HIV mRNA Vaccine Pipeline
DEVELOPMENT
PRECLINCAL
PHASE 1
PHASE 2
PHASE 3
INDICATION
HIV mRNA Vaccine (HIV-mRNA)
GLOBAL PUBLIC HEALTH IMPACT
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine
PARTNERS / SUPPORTERS
mRNA UCV Consortium
COMMERCIAL
Normax
LICENSING
Vaxcomm
HIV mRNA Vaccine Pipeline
INDICATION
HIV mRNA Vaccine
TECHNOLOGY
Prophylactic mRNA Vaccine. Therapeutic mRNA Vaccine
PARTNERS / SUPPORTERS
mRNA UCV Consortium
COMMERCIAL
Normax
LICENSING
Vaxcomm
Pricing Objective
Our goal is to be able to mass-produce a vaccine that is both highly efficient and affordable for the general public, that we will be able to distribute at the cost of about $4 per dose on large-scale APAs.
According to JAMA, the treatment of HIV costs between $36 080 to $48 000 (2018) per patient, per year, in the U.S.